Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT02213497
PHASE1
Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
View on ClinicalTrials.gov
Summary
Patients with esophageal cancer to be treated with concurrent preoperative proton therapy along with carboplatin and paclitaxel.
Official title: Phase I Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2014-04
Completion Date
2026-12-31
Last Updated
2026-01-08
Healthy Volunteers
No
Conditions
Interventions
RADIATION
18F-FDG (Fluorodeoxyglucose) PET
DRUG
Carboplatin
DRUG
Paclitaxel
Locations (1)
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States